USANA

MagneCal D Chewable

F
N+ Score58
Joint & BoneServing: 2 Tablet(s)Type: Other Combinations

USANA's MagneCal D Chewable is a joint and bone health supplement, containing 3 ingredients with full label transparency. It received an N+ Score of 58, resulting in an 'F' grade, placing it in the average quality tier. Each two-tablet serving delivers 260mg of Calcium and 260mg of Magnesium, both of which are at dosages considered clinically relevant for supporting bone mineral density. However, the product provides 12.5mcg of Vitamin D3, which is identified as underdosed compared to amounts often recommended for optimal bone health and absorption of calcium. The limited ingredient count and formula completeness contribute to its overall score. This supplement may be beneficial for individuals looking for basic calcium and magnesium support in a chewable format.

About This Product

MagneCal D Chewable by USANA is a joint & bone supplement containing 3 active ingredients. It has earned an N+ Score of 58/100 (Grade F).

Notable clinical-dose ingredients include Calcium, Magnesium.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity72/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +2 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Calcium260.000 mgAdequate
Magnesium260.000 mgOptimal
Vitamin D312.500 mcgUnder

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.